| Home | Generics | Biosimilars | Docs & Positions | Facts & Figures | Press Room | Conferences | Links |
![]() Generics medicines: a tradition of quality, safety & efficacy.About GenericsOverviewThe Science of Generic MedicinesOverview Guaranteed Quality Authorisation PharmacovigilanceBiosimilar MedicinesPresentationAffordability & Sustainable HealthOverviewIntellectual PropertyOverviewFurther ResourcesBibliography |
Generic Medicines and ScienceThe Science of Generic MedicinesQuality, Safety & EfficacyFor generic medicines, as with all other pharmaceutical products, scientifically controlled quality is of paramount importance. Generics producers seeking marketing approval in the EU must comply with stringent rules and regulations ... Marketing AuthorisationEU marketing authorisation for pharmaceutical products must be applied for through the "Centralised Procedure" or the “Mutual Recognition Procedure” (MRP). A new “Decentralised Procedure” was introduced in 2005 ... PharmacovigilanceMonitoring the use and effects of a given medication to detect and prevent adverse drug reactions (ADR) is the domain of what is known as pharmacovigilance ...
New medicinal treatments derived from biotechnology are increasingly available to healthcare markets. The downside to these new "miracle treatments" is the price of originator products ... |
| Copyright © 2004 EGA - European Generic medicines Association • • Cascading Pop-up Menus ©Angus Turnbull |
